Michael Robertson

  • 9972 Citations
  • 52 h-Index
1976 …2018
If you made any changes in Pure, your changes will be visible here soon.

Publications 1988 2018

  • 9972 Citations
  • 52 h-Index
  • 109 Article
2018
1 Citation (Scopus)

A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination with Ofatumumab after Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma

Robertson, M., Stamatkin, C. W., Pelloso, D., Weisenbach, J., Prasad, N. K. & Safa, A., Jan 1 2018, In : Journal of Immunotherapy. 41, 3, p. 151-157 7 p.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
Interleukin-18
Lymphoma
Intravenous Infusions
Natural Killer Cells
1 Citation (Scopus)
Germ Cell and Embryonal Neoplasms
Stem Cell Transplantation
Costs and Cost Analysis
Transplants
Length of Stay
2017
9 Citations (Scopus)

High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation

Farag, S., Nelson, R., Cairo, M. S., O'Leary, H. A., Zhang, S., Huntley, C., Delgado, D., Schwartz, J., Zaid, M. A., Abonour, R., Robertson, M. & Broxmeyer, H., Jan 1 2017, In : Oncotarget. 8, 66, p. 110350-110357 8 p.

Research output: Contribution to journalArticle

Fetal Blood
Transplantation
Neutrophils
Sitagliptin Phosphate
Transplants
2016
13 Citations (Scopus)

Cognitive and situational precipitants of loneliness among patients with cancer: A qualitative analysis

Adams, R. N., Mosher, C. E., Abonour, R., Robertson, M., Champion, V. & Kroenke, K., Mar 1 2016, In : Oncology Nursing Forum. 43, 2, p. 156-163 8 p.

Research output: Contribution to journalArticle

Loneliness
Neoplasms
Interviews
Nursing Assessment
Social Isolation
2015

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

Khawaja, M. R., Perkins, S., Schwartz, J. E., Robertson, M., Kiel, P. J., Sayar, H., Cox, E. A., Vance, G., Farag, S., Cripe, L. & Nelson, R., Feb 1 2015, In : American Journal of Hematology. 90, 2, p. 97-99 3 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Cyclophosphamide
Survival
Recurrence
Disease-Free Survival
22 Citations (Scopus)

Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial

Goy, A., Kalayoglu Besisik, S., Drach, J., Ramchandren, R., Robertson, M., Avivi, I., Rowe, J. M., Herbrecht, R., Van Hoof, A., Zhang, L., Cicero, S., Fu, T. & Witzig, T., Aug 1 2015, In : British Journal of Haematology. 170, 4, p. 496-503 8 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cell Proliferation
Neoplasms
Survival
Mitoxantrone
2014
10 Citations (Scopus)

Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvant

Tung, C. Y., Lewis, D. E., Han, L., Jaja, M., Yao, S., Li, F., Robertson, M., Zhou, B., Sun, J. & Chang, H. C., 2014, In : Vaccine. 32, 42, p. 5411-5419 9 p.

Research output: Contribution to journalArticle

vaccine adjuvants
ovalbumin
Ovalbumin
dendritic cells
Dendritic Cells
39 Citations (Scopus)

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

Levy, R., Ganjoo, K. N., Leonard, J. P., Vose, J. M., Flinn, I. W., Ambinder, R. F., Connors, J. M., Berinstein, N. L., Belch, A. R., Bartlett, N. L., Nichols, C., Emmanouilides, C. E., Timmerman, J. M., Gregory, S. A., Link, B. K., Inwards, D. J., Freedman, A. S., Matous, J. V., Robertson, M., Kunkel, L. A. & 6 others, Ingolia, D. E., Gentles, A. J., Liu, C. L., Tibshirani, R., Alizadeh, A. A. & Denney, D. W., Jun 10 2014, In : Journal of Clinical Oncology. 32, 17, p. 1797-1803 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Immunotherapy
Vaccination
Disease-Free Survival
Granulocyte-Macrophage Colony-Stimulating Factor
8 Citations (Scopus)

Overexpression of type VI collagen in neoplastic lung tissues

Voiles, L., Lewis, D. E., Han, L., Lupov, I. P., Lin, T. L., Robertson, M., Petrache, I. & Chang, H. C., Nov 1 2014, In : Oncology Reports. 32, 5, p. 1897-1904 8 p.

Research output: Contribution to journalArticle

Collagen Type VI
Lung
Interleukin-23
Lung Neoplasms
Focal Adhesion Protein-Tyrosine Kinases
20 Citations (Scopus)

Soypeptide lunasin in cytokine immunotherapy for lymphoma

Chang, H. C., Lewis, D., Tung, C. Y., Han, L., Henriquez, S. M. P., Voiles, L., Lupov, I. P., Pelloso, D., Sinn, A. L., Pollok, K., De Lumen, B. O., Li, F., Blum, J., Srivastava, S. & Robertson, M., Mar 2014, In : Cancer Immunology Immunotherapy. 63, 3, p. 283-295 13 p.

Research output: Contribution to journalArticle

Immunotherapy
Lymphoma
Cytokines
Natural Killer Cells
Interleukin-12
2013
14 Citations (Scopus)

A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-hodgkin Lymphoma

Robertson, M., Kline, J., Struemper, H., Koch, K. M., Bauman, J. W., Gardner, O. S., Murray, S. C., Germaschewski, F., Weisenbach, J., Jonak, Z. & Toso, J. F., Jul 2013, In : Journal of Immunotherapy. 36, 6, p. 331-341 11 p.

Research output: Contribution to journalArticle

Interleukin-18
Non-Hodgkin's Lymphoma
Lymphopenia
B-Cell Lymphoma
Lymphoma
35 Citations (Scopus)

Effects of interleukin-18 on natural killer cells: Costimulation of activation through Fc receptors for immunoglobulin

Srivastava, S., Pelloso, D., Feng, H., Voiles, L., Lewis, D., Haskova, Z., Whitacre, M., Trulli, S., Chen, Y. J., Toso, J., Jonak, Z. L., Chang, H. C. & Robertson, M., Jun 2013, In : Cancer Immunology Immunotherapy. 62, 6, p. 1073-1082 10 p.

Research output: Contribution to journalArticle

Immunoglobulin Fc Fragments
Interleukin-18
Fc Receptors
Natural Killer Cells
Monoclonal Antibodies
68 Citations (Scopus)

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies

Farag, S., Srivastava, S., Messina-Graham, S., Schwartz, J., Robertson, M., Abonour, R., Cornetta, K., Wood, L., Secrest, A., Strother, R. M., Jones, D. R. & Broxmeyer, H., Apr 1 2013, In : Stem Cells and Development. 22, 7, p. 1007-1015 9 p.

Research output: Contribution to journalArticle

Dipeptidyl Peptidase 4
Hematologic Neoplasms
Fetal Blood
Transplants
Stem Cells
1 Citation (Scopus)

Primary effusion anaplastic large cell lymphoma in a patient with long-standing dermatitis herpetiformis and celiac disease

Nassiri, M., Robertson, M., Hertzberg, L. & Czader, M., Jan 2013, In : Annals of Hematology. 92, 2, p. 279-281 3 p.

Research output: Contribution to journalArticle

2011
16 Citations (Scopus)

Acquired STAT4 deficiency as a consequence of cancer chemotherapy

Lupov, I. P., Voiles, L., Han, L., Schwartz, A., De La Rosa, M., Oza, K., Pelloso, D., Sahu, R. P., Travers, J., Robertson, M. & Chang, H. C., Dec 1 2011, In : Blood. 118, 23, p. 6097-6106 10 p.

Research output: Contribution to journalArticle

STAT4 Transcription Factor
Chemotherapy
STAT Transcription Factors
Drug Therapy
Neoplasms
6 Citations (Scopus)

A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory Non-Hodgkin lymphoma

Srivastava, S., Jones, D., Wood, L. L., Schwartz, J. E., Nelson, R., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K., Robertson, M. & Farag, S., Jul 2011, In : Biology of Blood and Marrow Transplantation. 17, 7, p. 987-994 8 p.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
Etoposide
Non-Hodgkin's Lymphoma
Cyclophosphamide
Maximum Tolerated Dose
28 Citations (Scopus)

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.

Farag, S., Wood, L. L., Schwartz, J. E., Srivastava, S., Nelson, R., Robertson, M., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K. & Jones, D. R., Apr 2011, In : Leukemia. 25, 4, p. 599-605 7 p.

Research output: Contribution to journalArticle

Busulfan
Stem Cell Transplantation
Leukemia
Pharmacokinetics
Maximum Tolerated Dose
23 Citations (Scopus)

Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation

Rosenbeck, L. L., Kiel, P. J., Kalsekar, I., Vargo, C., Baute, J., Sullivan, C. K., Wood, L., Abdelqader, S., Schwartz, J., Srivastava, S., Abonour, R., Robertson, M., Nelson, R., Cornetta, K., Fausel, C. A. & Farag, S., Jun 2011, In : Biology of Blood and Marrow Transplantation. 17, 6, p. 916-922 7 p.

Research output: Contribution to journalArticle

Antilymphocyte Serum
Stem Cell Transplantation
Tacrolimus
Graft vs Host Disease
Sirolimus
2010
52 Citations (Scopus)

Interleukin-18: Biology and role in the immunotherapy of cancer

Srivastava, S., Salim, N. & Robertson, M., 2010, In : Current Medicinal Chemistry. 17, 29, p. 3353-3357 5 p.

Research output: Contribution to journalArticle

Interleukin-18
Immunotherapy
Neoplasms
T-cells
Cytokines
13 Citations (Scopus)

Long-term disease-free survival after nonmyeloablative cyclophosphamide/ fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia

Nelson, R., Yu, M., Schwartz, J. E., Robertson, M., Hromas, R., Fausel, C. A., Vance, G., Dlouhy, S., Baute, J. A., Cox, E. A., Wood, L. L., Srivastava, S., Robertson, K., Haut, P., Farag, S., Abonour, R., Cornetta, K. & Cripe, L., Aug 2010, In : Bone Marrow Transplantation. 45, 8, p. 1300-1308 9 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Cyclophosphamide
Disease-Free Survival
Unrelated Donors
Survivors
1 Citation (Scopus)
Juvenile Arthritis
Whole-Body Irradiation
Immunosuppressive Agents
Recurrence
Peripheral Blood Stem Cells
349 Citations (Scopus)

The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation

Chang, H. C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A. N., Han, L., Nguyen, E. T., Robertson, M., Perumal, N. B., Tepper, R., Nutt, S. L. & Kaplan, M., Jun 2010, In : Nature Immunology. 11, 6, p. 527-534 8 p.

Research output: Contribution to journalArticle

Interleukin-9
Inflammation
T-Lymphocytes
Helper-Inducer T-Lymphocytes
Phenotype
2009
244 Citations (Scopus)

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: Updated time-to-event analyses of the multicenter phase 2 PINNACLE study

Goy, A., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M., de Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., Nasta, S., O'Connor, O. A., Shi, H., Boral, A. L. & Fisher, R. I., 2009, In : Annals of Oncology. 20, 3, p. 520-525 6 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Survival
Bortezomib
Therapeutics
Multicenter Studies
33 Citations (Scopus)

Impaired development of human Th1 cells in patients with deficient expression of STAT4

Chang, H. C., Han, L., Goswami, R., Nguyen, E. T., Pelloso, D., Robertson, M. & Kaplan, M., 2009, In : Blood. 113, 23, p. 5887-5890 4 p.

Research output: Contribution to journalArticle

Th1 Cells
T-cells
Human Development
Cell culture
Interleukin-5
105 Citations (Scopus)

Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma

Freedman, A., Neelapu, S. S., Nichols, C., Robertson, M., Djulbegovic, B., Winter, J. N., Bender, J. F., Gold, D. P., Ghalie, R. G., Stewart, M. E., Esquibel, V. & Hamlin, P., Jun 20 2009, In : Journal of Clinical Oncology. 27, 18, p. 3036-3043 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Granulocyte-Macrophage Colony-Stimulating Factor
Immunotherapy
Placebos
Random Allocation
Stem Cell Transplantation
Hodgkin Disease
Drug Therapy
Therapeutics
2008
57 Citations (Scopus)

A dose-escalation study of recombinant human Lnterleukin-18 using two different schedules of administration in patients with cancer

Robertson, M., Kirkwood, J. M., Logan, T., Koch, K. M., Kathman, S., Kirby, L. C., Bell, W. N., Weisenbach, J., Thurmond, L. M. & Dar, M. M., Jun 1 2008, In : Clinical Cancer Research. 14, 11, p. 3462-3469 8 p.

Research output: Contribution to journalArticle

Appointments and Schedules
Lymphopenia
Interleukin-18
Pharmacokinetics
Hypoalbuminemia
2007
213 Citations (Scopus)

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma

Robertson, M., Kahl, B. S., Vose, J. M., De Vos, S., Laughlin, M., Flynn, P. J., Rowland, K., Cruz, J. C., Goldberg, S. L., Musib, L., Darstein, C., Enas, N., Kutok, J. L., Aster, J. C., Neuberg, D., Savage, K. J., LaCasce, A., Thornton, D., Slapak, C. A. & Shipp, M. A., May 1 2007, In : Journal of Clinical Oncology. 25, 13, p. 1741-1746 6 p.

Research output: Contribution to journalArticle

Protein Kinase C beta
Lymphoma, Large B-Cell, Diffuse
enzastaurin
Therapeutics
Stem Cell Transplantation
2006
91 Citations (Scopus)

Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer.

Robertson, M., Mier, J. W., Logan, T., Atkins, M., Koon, H., Koch, K. M., Kathman, S., Pandite, L. N., Oei, C., Kirby, L. C., Jewell, R. C., Bell, W. N., Thurmond, L. M., Weisenbach, J., Roberts, S. & Dar, M. M., Jul 15 2006, In : Clinical Cancer Research. 12, 14 Pt 1, p. 4265-4273 9 p.

Research output: Contribution to journalArticle

Interleukin-18
Intravenous Infusions
Neoplasms
Hypotension
Pharmacokinetics
7 Citations (Scopus)

Interleukins 18 and 21: Biology, mechanisms of action, toxicity, and clinical activity

Logan, T. F. & Robertson, M. J., Mar 2006, In : Current Oncology Reports. 8, 2, p. 114-119 6 p.

Research output: Contribution to journalArticle

Interleukin-18
Neoplasms
Clinical Trials, Phase I
Interleukins
Animal Models
36 Citations (Scopus)

Macrophage activation syndrome and other systemic inflammatory conditions after BMT

Sreedharan, A., Bowyer, S., Wallace, C. A., Robertson, M., Schmidt, K., Woolfrey, A. E. & Nelson, R., Apr 2006, In : Bone Marrow Transplantation. 37, 7, p. 629-634 6 p.

Research output: Contribution to journalArticle

Macrophage Activation Syndrome
Hemophagocytic Lymphohistiocytosis
Disseminated Intravascular Coagulation
Cell Transplantation
Pancytopenia
574 Citations (Scopus)

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

Fisher, R. I., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M., De Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., Stadtmauer, E. A., O'Connor, O. A., Shi, H., Boral, A. L. & Goy, A., Oct 20 2006, In : Journal of Clinical Oncology. 24, 30, p. 4867-4874 8 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Radiology
Research Personnel
Safety
Survival
96 Citations (Scopus)

Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis

Ganjoo, K., An, C., Robertson, M., Gordon, L., Sen, J., Weisenbach, J., Li, S., Weller, E., Orazi, A. & Horning, S., Jun 2006, In : Leukemia and Lymphoma. 47, 6, p. 998-1005 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Vascular Endothelial Growth Factor A
Pharmacokinetics
Biomarkers
Safety
89 Citations (Scopus)

The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: Implications for the downregulation of CXCL14 in malignancy

Starnes, T., Rasila, K. K., Robertson, M., Brahmi, Z., Dahl, R., Christopherson, K. & Hromas, R., Aug 2006, In : Experimental Hematology. 34, 8, p. 1101-1105 5 p.

Research output: Contribution to journalArticle

Chemokines
Natural Killer Cells
Cell Movement
Chemotaxis
Down-Regulation
2005
7 Citations (Scopus)

A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: A hoosier oncology group study

Ganjoo, K. N., Robertson, M., Fisher, W., Jung, S. H., McClean, J., Huh, S. Y., Bufill, J., Williams, S. & Cripe, L., Apr 2005, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 28, 2, p. 169-172 4 p.

Research output: Contribution to journalArticle

gemcitabine
Non-Hodgkin's Lymphoma
Proxy
B-Cell Chronic Lymphocytic Leukemia
Neutropenia
9 Citations (Scopus)
Carmustine
Hematopoietic Stem Cell Transplantation
Etoposide
Non-Hodgkin's Lymphoma
Cyclophosphamide
17 Citations (Scopus)

Impaired interferon-γ production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma

Robertson, M. J., Chang, H. C., Pelloso, D. & Kaplan, M. H., Aug 1 2005, In : Blood. 106, 3, p. 963-970 8 p.

Research output: Contribution to journalArticle

STAT4 Transcription Factor
Hematopoietic Stem Cell Transplantation
Stem cells
Interferons
Lymphoma
64 Citations (Scopus)

Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression

Robertson, M., Schacterle, R. S., Mackin, G. A., Wilson, S. N., Bloomingdale, K. L., Ritz, J. & Komaroff, A. L., Aug 2005, In : Clinical and Experimental Immunology. 141, 2, p. 326-332 7 p.

Research output: Contribution to journalArticle

Chronic Fatigue Syndrome
Lymphocyte Subsets
Multiple Sclerosis
Natural Killer Cells
B-Lymphocyte Subsets
2004
9 Citations (Scopus)

Immunological Consequences of Interleukin 12 Administration after Autologous Stem Cell Transplantation

Pelloso, D., Cyran, K., Timmons, L., Williams, B. T. & Robertson, M., Mar 15 2004, In : Clinical Cancer Research. 10, 6, p. 1935-1942 8 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Interleukin-12
Natural Killer Cells
T-Lymphocytes
Therapeutics
66 Citations (Scopus)

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease

Younes, A., Pro, B., Robertson, M., Flinn, I. W., Romaguera, J. E., Hagemeister, F., Dang, N. H., Fiumara, P., Loyer, E. M., Cabanillas, F. F., McLaughlin, P. W., Rodriguez, M. A. & Samaniego, F., Aug 15 2004, In : Clinical Cancer Research. 10, 16, p. 5432-5438 7 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Interleukin-12
Hodgkin Disease
Non-Hodgkin's Lymphoma
Therapeutics
2002
192 Citations (Scopus)

Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis

Starnes, T., Broxmeyer, H., Robertson, M. & Hromas, R., Jul 15 2002, In : Journal of Immunology. 169, 2, p. 642-646 5 p.

Research output: Contribution to journalArticle

Interleukin-27
Interleukin-17
Interleukin-8
Cytokines
Myeloid Progenitor Cells
30 Citations (Scopus)

Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies

Robertson, M., Pelloso, D., Abonour, R., Hromas, R. A., Nelson, R., Wood, L. & Cornetta, K., Nov 1 2002, In : Clinical Cancer Research. 8, 11, p. 3383-3393 11 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Hematologic Neoplasms
Interleukin-12
Immunotherapy
Liver Function Tests
342 Citations (Scopus)

Role of chemokines in the biology of natural killer cells

Robertson, M., Feb 1 2002, In : Journal of Leukocyte Biology. 71, 2, p. 173-183 11 p.

Research output: Contribution to journalArticle

Chemokines
Natural Killer Cells
CCR Receptors
Muromegalovirus
Leishmania major
2001
2 Citations (Scopus)
Animal Disease Models
Epstein-Barr Virus Infections
SCID Mice
Lymphoproliferative Disorders
Granulocyte-Macrophage Colony-Stimulating Factor
274 Citations (Scopus)

Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production

Starnes, T., Robertson, M., Sledge, G., Kelich, S., Nakshatri, H., Broxmeyer, H. & Hromas, R., Oct 15 2001, In : Journal of Immunology. 167, 8, p. 4137-4140 4 p.

Research output: Contribution to journalArticle

Interleukin-17
Monocytes
Endothelial Cells
Cytokines
T-Lymphocytes
2000

Activation of primary human chronic lymphocytic leukemia (cll) cells by interleukin-2 (il-2): implications for cancer vaccine development

Robertson, M., Ganjoo, K. & Timmons, L., 2000, In : Blood. 96, 11 PART II

Research output: Contribution to journalArticle

Cancer Vaccines
B-Cell Chronic Lymphocytic Leukemia
Interleukin-2
Chemical activation
Cell culture

Efficient retroviral vector - mediated gene transfer into primary human chronic lymphocytic leukemia (CLL) cells after short term in vitro culture

Robertson, M., Cripe, L., Ganjoo, K., Timmons, L. & Cornelia, K., 2000, In : Blood. 96, 11 PART II

Research output: Contribution to journalArticle

Gene transfer
B-Cell Chronic Lymphocytic Leukemia
Interleukin-2
Genes
Fluorescence
238 Citations (Scopus)

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells

Abonour, R., Williams, D. A., Einhorn, L., Hall, K. M., Chen, J., Coffman, J., Orschell, C., Bank, A., Kato, I., Ward, M., Williams, S. D., Hromas, R., Robertson, M., Smith, F. O., Woo, D., Mills, B., Srour, E. & Cornetta, K., Jun 2000, In : Nature Medicine. 6, 6, p. 652-658 7 p.

Research output: Contribution to journalArticle

MDR Genes
Retroviridae
Hematopoietic Stem Cells
Stem cells
Gene transfer
38 Citations (Scopus)

Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines

Robertson, M., Williams, B. T., Christopherson, K., Brahmi, Z. & Hromas, R., Jan 10 2000, In : Cellular Immunology. 199, 1, p. 8-14 7 p.

Research output: Contribution to journalArticle

CC Chemokines
Natural Killer Cells
Cell Movement
Cell Proliferation
Chemotaxis
1 Citation (Scopus)
Melphalan
Stem Cells
Transplants
Blood
Granulocyte Colony-Stimulating Factor